NovaBay Pharmaceuticals
NBYNBY · Stock Price
Historical price data
Overview
NovaBay Pharmaceuticals is undergoing a reverse merger to transform into Stablecoin Development Corporation (SDEV), with the ticker change to SDEV effective April 6, 2026. The company's mission is to build a publicly traded platform focused on the stablecoin ecosystem, beginning with a strategic, revenue-generating position in the Sky Protocol. Its strategy leverages its significant SKY token holdings to capture value from the protocol's substantial fee generation and aims to expand into broader digital financial infrastructure opportunities. This move creates a novel public market vehicle for direct exposure to the economic activity of leading decentralized finance protocols.
Technology Platform
The company's value is tied to the Sky Protocol, a decentralized finance platform that issues USDS, a yield-bearing, fully collateralized stablecoin, and uses the SKY token for governance and fee distribution.
Funding History
4Opportunities
Risk Factors
Competitive Landscape
As an investment vehicle, it is a unique public equity proxy for DeFi. Its underlying asset, Sky Protocol, competes with giant non-yielding stablecoins (USDT, USDC) and other DeFi protocols, differentiating itself via native yield from high protocol fees and a robust Peg Stability Module.
Company Timeline
Founded in Emeryville, United States
IPO — $30.0M
Series B: $25.0M
PIPE: $15.0M